Skip to main content
. 2022 Jan 12;17(1):e0261786. doi: 10.1371/journal.pone.0261786

Fig 3. Propensity-weighted cumulative event rate curves for secondary outcomes.

Fig 3

Hazard ratios with 95% confidence intervals are shown. After weighting, cohorts were balanced across 49 covariates including demographics, medication use, and clinical comorbidities associated with arterial and venous thromboembolism.